Multiple Dose Study of Safety and Pharmacokinetics of MEDI0618 in Healthy Volunteers

Trial Identifier:	D7060C00002
Sponsor:	AstraZeneca
NCTID::	NCT05714254
Start Date:	December 2022
Primary Completion Date:	December 2023
Study Completion Date:	December 2023
Condition:	Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
DE	Berlin, DE, 10117

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.